Literature DB >> 12819066

Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge.

Helen S Garmory1, Richard W Titball, Kate F Griffin, Ulrike Hahn, Reinhard Böhm, Wolfgang Beyer.   

Abstract

Protective immunity against infection with Bacillus anthracis is almost entirely based on a response to the protective antigen (PA), the binding moiety for the two other toxin components. We cloned the PA gene into an auxotrophic mutant of Salmonella enterica serovar Typhimurium as a fusion with the signal sequence of the hemolysin (Hly) A gene of Escherichia coli to allow the export of PA via the Hly export system. To stabilize the export cassette, it was also integrated into the chromosome of the live Salmonella carrier. When S. enterica serovar Typhimurium with the chromosomally integrated PA gene was given intravenously to A/J mice, they developed high levels of antibody to PA. These mice were protected against intraperitoneal challenge with 100 or 1,000 50% lethal doses of B. anthracis strain STI. This work contributes to the development of a Salmonella-based orally delivered anthrax vaccine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819066      PMCID: PMC162028          DOI: 10.1128/IAI.71.7.3831-3836.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA.

Authors:  N Orr; J E Galen; M M Levine
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria.

Authors:  V de Lorenzo; M Herrero; U Jakubzik; K N Timmis
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

Review 3.  Common themes in microbial pathogenicity.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Rev       Date:  1989-06

Review 4.  Salmonella vaccines for use in humans: present and future perspectives.

Authors:  Helen S Garmory; Katherine A Brown; Richard W Titball
Journal:  FEMS Microbiol Rev       Date:  2002-11       Impact factor: 16.408

5.  The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

Authors:  S Welkos; S Little; A Friedlander; D Fritz; P Fellows
Journal:  Microbiology       Date:  2001-06       Impact factor: 2.777

6.  Passive transfer of protection against Bacillus anthracis infection in a murine model.

Authors:  R J Beedham; P C Turnbull; E D Williamson
Journal:  Vaccine       Date:  2001-08-14       Impact factor: 3.641

7.  Molecular analysis of hemolysin-mediated secretion of a human interleukin-6 fusion protein in Salmonella typhimurium.

Authors:  Y Li; C Hess; B von Specht; H P Hahn
Journal:  FEMS Immunol Med Microbiol       Date:  2000-04

8.  A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection.

Authors:  Helen C Flick-Smith; Nicola J Walker; Paula Gibson; Helen Bullifent; Sarah Hayward; Julie Miller; Richard W Titball; E Diane Williamson
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

9.  Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants.

Authors:  B E Ivins; S L Welkos; S F Little; M H Crumrine; G O Nelson
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

10.  Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis.

Authors:  S L Welkos; J R Lowe; F Eden-McCutchan; M Vodkin; S H Leppla; J J Schmidt
Journal:  Gene       Date:  1988-09-30       Impact factor: 3.688

View more
  16 in total

1.  Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.

Authors:  Leslie W J Baillie; Ana L Rodriguez; Stephen Moore; Helen S Atkins; Chiguang Feng; James P Nataro; Marcela F Pasetti
Journal:  Vaccine       Date:  2008-09-19       Impact factor: 3.641

Review 2.  The Bacillus cereus Group: Bacillus Species with Pathogenic Potential.

Authors:  Monika Ehling-Schulz; Didier Lereclus; Theresa M Koehler
Journal:  Microbiol Spectr       Date:  2019-05

3.  Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.

Authors:  Margaret G M Stokes; Richard W Titball; Brendan N Neeson; James E Galen; Nicola J Walker; Anthony J Stagg; Dominic C Jenner; Joanne E Thwaite; James P Nataro; Leslie W J Baillie; Helen S Atkins
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

4.  Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.

Authors:  Kristin H Clement; Thomas L Rudge; Heather J Mayfield; Lena A Carlton; Arelis Hester; Nancy A Niemuth; Carol L Sabourin; April M Brys; Conrad P Quinn
Journal:  Clin Vaccine Immunol       Date:  2010-08-25

5.  Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.

Authors:  R Aloni-Grinstein; O Gat; Z Altboum; B Velan; S Cohen; A Shafferman
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.

Authors:  Manuel Osorio; Yanping Wu; Sunil Singh; Tod J Merkel; Siba Bhattacharyya; Milan S Blake; Dennis J Kopecko
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

Review 7.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

8.  Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.

Authors:  Johnny W Peterson; Jason E Comer; Wallace B Baze; David M Noffsinger; Autumn Wenglikowski; Kristin G Walberg; Jason Hardcastle; Jennifer Pawlik; Kathryn Bush; Joanna Taormina; Scott Moen; John Thomas; Bagram M Chatuev; Laurie Sower; Ashok K Chopra; Lawrence R Stanberry; Ritsuko Sawada; Wolfgang W Scholz; Jagadish Sircar
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

9.  Attenuated Salmonella typhimurium carrying the hepatocyte growth factor and keratinocyte growth factor genes repairs gastrointestinal mucosal damage caused by chemotherapy.

Authors:  Jun-Zhong Sun; Xiao-Qin Ha; Li-Ming Zhang; Hai-Bin Wang; Hong-Wei Wang; Hai-Feng Duan
Journal:  Med Oncol       Date:  2013-01-19       Impact factor: 3.064

Review 10.  Salmonella enterica serovar Typhi live vector vaccines finally come of age.

Authors:  James E Galen; Marcela F Pasetti; Sharon Tennant; Patricia Ruiz-Olvera; Marcelo B Sztein; Myron M Levine
Journal:  Immunol Cell Biol       Date:  2009-05-05       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.